0000313212-24-000277.txt : 20240328 0000313212-24-000277.hdr.sgml : 20240328 20240328125524 ACCESSION NUMBER: 0000313212-24-000277 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240131 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 PERIOD START: 20241031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T. Rowe Price International Funds, Inc. CENTRAL INDEX KEY: 0000313212 ORGANIZATION NAME: IRS NUMBER: 521175211 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-02958 FILM NUMBER: 24796691 BUSINESS ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-345-2000 MAIL ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INTERNATIONAL FUNDS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INTERNATIONAL TRUST DATE OF NAME CHANGE: 19900301 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INTERNATIONAL FUND INC DATE OF NAME CHANGE: 19890914 0000313212 S000046336 T. Rowe Price International Disciplined Equity Fund C000144795 T. Rowe Price International Disciplined Equity Fund PRCNX C000144796 T. Rowe Price International Disciplined Equity Fund-Advisor Class PRNCX C000184324 T. Rowe Price International Disciplined Equity Fund-I Class RICIX NPORT-P 1 primary_doc.xml NPORT-P false 0000313212 XXXXXXXX S000046336 C000144796 C000184324 C000144795 T. ROWE PRICE INTERNATIONAL FUNDS, INC. 811-02958 0000313212 549300O4BT3AMY6OUC26 100 East Pratt Street Baltimore 21202 410-345-2000 T. Rowe Price International Disciplined Equity Fund S000046336 54930050ONZ3GNNPPL95 2024-10-31 2024-01-31 N 349228648.300000 17168367.300000 332060281.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 58343.200000 USD N BHP Group Ltd WZE1WSENV6JSZFK0JC28 BHP GROUP LTD 000000000 154095.000000 NS 4720056.120000 1.4214455598 Long EC CORP AU N 2 N N N Diageo PLC 213800ZVIELEA55JMJ32 DIAGEO PLC 000000000 127514.000000 NS 4605532.930000 1.3869568851 Long EC CORP GB N 2 N N N HSBC Holdings PLC MLU0ZO3ML4LN2LL2TL39 HSBC HOLDINGS PLC 000000000 591431.000000 NS 4617717.810000 1.3906263634 Long EC CORP GB N 2 N N N Prudential PLC 5493001Z3ZE83NGK8Y12 PRUDENTIAL PLC 000000000 553533.000000 NS 5686204.680000 1.7124013335 Long EC CORP GB N 2 N N N BP PLC 213800LH1BZH3DI6G760 BP PLC 000000000 966027.000000 NS 5641999.670000 1.6990889886 Long EC CORP GB N 2 N N N Lloyds Banking Group PLC 549300PPXHEU2JF0AM85 LLOYDS BANKING GROUP PLC 000000000 7954463.000000 NS 4264036.070000 1.2841150580 Long EC CORP GB N 2 N N N Smith & Nephew PLC 213800ZTMDN8S67S1H61 SMITH & NEPHEW PLC 000000000 297870.000000 NS 4165711.900000 1.2545047205 Long EC CORP GB N 2 N N N Power Corp of Canada 549300BE2CB8T87IJV50 POWER CORP OF CANADA 000000000 112737.000000 NS 3286223.390000 0.9896466329 Long EC CORP CA N 2 N N N HAL Trust 5493000O3IE3DNOY3R07 HAL TRUST 000000000 35697.000000 NS 4449719.630000 1.3400336880 Long EC CORP BM N 2 N N N L E Lundbergforetagen AB 529900BPSFZS6O3A9R04 L E LUNDBERGFORETAGEN AB 000000000 93014.000000 NS 4849825.920000 1.4605257532 Long EC CORP SE N 2 N N Continental AG 529900A7YD9C0LLXM621 CONTINENTAL AG 000000000 57226.000000 NS 4674831.630000 1.4078261983 Long EC CORP DE N 2 N N N iShares MSCI EAFE ETF 549300O0XO3KDQV68404 ISHARES MSCI EAFE ETF 464287465 119700.000000 NS USD 8978697.000000 2.7039358556 Long EC RF US N 1 N N Schneider Electric SE 969500A1YF1XUYYXS284 SCHNEIDER ELECTRIC SE 000000000 15935.000000 NS 3130432.870000 0.9427302960 Long EC CORP FR N 2 N N N Storebrand ASA 5967007LIEEXZX7NA051 STOREBRAND ASA 000000000 450035.000000 NS 4046340.420000 1.2185559826 Long EC CORP NO N 2 N N N Bayer AG 549300J4U55H3WP1XT59 BAYER AG 000000000 100754.000000 NS 3135123.380000 0.9441428438 Long EC CORP DE N 2 N N N Henkel AG & Co KGaA 549300VZCL1HTH4O4Y49 HENKEL AG & CO KGAA 000000000 55863.000000 NS 4282374.200000 1.2896375884 Long EP CORP DE N 2 N N N BASF SE 529900PM64WH8AF1E917 BASF SE 000000000 96755.000000 NS 4625275.280000 1.3929022966 Long EC CORP DE N 2 N N N Barry Callebaut AG 213800Y5RWKLDPUTT265 BARRY CALLEBAUT AG 000000000 3054.000000 NS 4460696.210000 1.3433392866 Long EC CORP CH N 2 N N N Volkswagen AG 529900NNUPAGGOMPXZ31 VOLKSWAGEN AG 000000000 40394.000000 NS 5195276.960000 1.5645583821 Long EP CORP DE N 2 N N N Fortum Oyj 635400IUIZZIUJSAMF76 FORTUM OYJ 000000000 297920.000000 NS 4072609.030000 1.2264667782 Long EC CORP FI N 2 N N N Sanofi SA 549300E9PC51EN656011 SANOFI SA 000000000 51831.000000 NS 5190642.310000 1.5631626566 Long EC CORP FR N 2 N N N Siemens AG W38RGI023J3WT1HWRP32 SIEMENS AG 000000000 29963.000000 NS 5364092.590000 1.6153972326 Long EC CORP DE N 2 N N N Koninklijke Philips NV H1FJE8H61JGM1JSGM897 KONINKLIJKE PHILIPS NV 000000000 165119.000000 NS 3493184.250000 1.0519729248 Long EC CORP NL N 2 N N N Hamamatsu Photonics KK N/A HAMAMATSU PHOTONICS KK 000000000 135300.000000 NS 5345014.180000 1.6096517668 Long EC CORP JP N 2 N N N Hoya Corp 353800X4VR3BHEUCJB42 HOYA CORP 000000000 25500.000000 NS 3239244.230000 0.9754988523 Long EC CORP JP N 2 N N N Jardine Matheson Holdings Ltd 2138009KENVUNWOLPK41 JARDINE MATHESON HOLDINGS LTD 000000000 131600.000000 NS USD 5284286.180000 1.5913635211 Long EC CORP BM N 2 N N N Kao Corp 353800HM38HFCB8RGL63 KAO CORP 000000000 93800.000000 NS 3711438.410000 1.1177001955 Long EC CORP JP N 2 N N N Kirin Holdings Co Ltd 353800GBVL72LLMTYM96 KIRIN HOLDINGS CO LTD 000000000 303200.000000 NS 4358186.170000 1.3124683738 Long EC CORP JP N 2 N N N Mitsubishi Electric Corp 549300TRXM9Y6561AX39 MITSUBISHI ELECTRIC CORP 000000000 289000.000000 NS 4288846.810000 1.2915868158 Long EC CORP JP N 2 N N N Nippon Sanso Holdings Corp 353800F1K6653B4VPY57 NIPPON SANSO HOLDINGS CORP 000000000 160100.000000 NS 4056823.180000 1.2217128672 Long EC CORP JP N 2 N N N Nippon Telegraph & Telephone Corp 353800VHQU5VIXVUA841 NIPPON TELEGRAPH & TELEPHONE CORP 000000000 2938000.000000 NS 3689407.920000 1.1110657104 Long EC CORP JP N 2 N N N Olympus Corp 5299000Y52IFDI1I2A21 OLYMPUS CORP 000000000 281800.000000 NS 4171672.000000 1.2562996054 Long EC CORP JP N 2 N N N Shimadzu Corp N/A SHIMADZU CORP 000000000 178900.000000 NS 4946939.480000 1.4897715153 Long EC CORP JP N 2 N N N Shimano Inc 529900L32YT3P9DECR10 SHIMANO INC 000000000 32400.000000 NS 4651840.770000 1.4009024976 Long EC CORP JP N 2 N N N Sony Group Corp 529900R5WX9N2OI2N910 SONY GROUP CORP 000000000 41500.000000 NS 4069838.490000 1.2256324297 Long EC CORP JP N 2 N N N Tokyo Electron Ltd 549300H5LSF8DP3RIJ34 TOKYO ELECTRON LTD 000000000 16400.000000 NS 3043388.280000 0.9165168056 Long EC CORP JP N 2 N N N Groupe Bruxelles Lambert NV 549300KV0ZEHT2KVU152 GROUPE BRUXELLES LAMBERT NV 000000000 84217.000000 NS 6384464.250000 1.9226823006 Long EC CORP BE N 2 N N N Novartis AG 5493007HIVTX6SY6XD66 NOVARTIS AG 000000000 41522.000000 NS 4293947.840000 1.2931229917 Long EC CORP CH N 2 N N N Roche Holding AG 549300U41AUUVOAAOB37 ROCHE HOLDING AG 000000000 21380.000000 NS 6087235.650000 1.8331718662 Long EC CORP CH N 2 N N N Nestle SA KY37LUS27QQX7BB93L28 NESTLE SA 000000000 61021.000000 NS 6953380.020000 2.0940113642 Long EC CORP CH N 2 N N N EssilorLuxottica SA 549300M3VH1A3ER1TB49 ESSILORLUXOTTICA SA 000000000 18559.000000 NS 3637064.080000 1.0953023557 Long EC CORP FR N 2 N N N Wendel SE 969500M98ZMIZYJD5O34 WENDEL SE 000000000 46827.000000 NS 4245457.150000 1.2785200137 Long EC CORP FR N 2 N N N T. Rowe Price Government Reserve Fund 5493002Y0IYARJVQ5N24 T. Rowe Price Government Reserve Fund 76105Y109 14045013.300000 NS USD 14045013.300000 4.2296577169 Long STIV RF US N 1 N N N T. Rowe Price Government Reserve Fund 5493002Y0IYARJVQ5N24 T. Rowe Price Government Reserve Fund \u2013 Collateral 76105YYY8 15516558.400000 NS USD 15516558.400000 4.6728137293 Long STIV RF US N 1 N N Heineken NV 724500K5PTPSST86UQ23 HEINEKEN NV 000000000 44608.000000 NS 4487363.480000 1.3513701387 Long EC CORP NL N 2 N N N Ayala Corp 254900QJ68UH8GKNGI69 AYALA CORP 000000000 373570.000000 NS 4501212.530000 1.3555407821 Long EC CORP PH N 2 N N N TotalEnergies SE 529900S21EQ1BO4ESM68 TOTALENERGIES SE 000000000 60380.000000 NS 3917187.050000 1.1796614272 Long EC CORP FR N 2 N N N Experian PLC 635400RXXHHYT1JTSZ26 EXPERIAN PLC 000000000 75521.000000 NS 3143364.950000 0.9466247937 Long EC CORP JE N 2 N N N Industrivarden AB 549300TM1DLIQI3B3T37 INDUSTRIVARDEN AB 000000000 154520.000000 NS 4856422.330000 1.4625122629 Long EC CORP SE N 2 N N Smiths Group PLC 213800MJL6IPZS3ASA11 SMITHS GROUP PLC 000000000 230866.000000 NS 4731283.710000 1.4248267501 Long EC CORP GB N 2 N N N Anglo American PLC 549300S9XF92D1X8ME43 ANGLO AMERICAN PLC 000000000 194513.000000 NS 4636738.370000 1.3963544077 Long EC CORP GB N 2 N N N Iberdrola SA 5QK37QC7NWOJ8D7WVQ45 IBERDROLA SA 000000000 294872.000000 NS 3550542.780000 1.0692464541 Long EC CORP ES N 2 N N N Hoshizaki Corp 5299001QAMLGU3SRBG20 HOSHIZAKI CORP 000000000 118400.000000 NS 4307555.730000 1.2972210097 Long EC CORP JP N 2 N N N Amadeus IT Group SA 9598004A3FTY3TEHHN09 AMADEUS IT GROUP SA 000000000 65793.000000 NS 4610798.310000 1.3885425550 Long EC CORP ES N 2 N N N Otsuka Holdings Co Ltd N/A OTSUKA HOLDINGS CO LTD 000000000 94600.000000 NS 3718567.070000 1.1198469925 Long EC CORP JP N 2 N N N Novozymes A/S 529900T6WNZXD2R3JW38 NOVOZYMES A/S 000000000 57586.000000 NS 2950746.990000 0.8886178682 Long EC CORP DK N 2 N N ASML Holding NV 724500Y6DUVHQD6OXN27 ASML HOLDING NV 000000000 7199.000000 NS 6245767.060000 1.8809136224 Long EC CORP NL N 2 N N N Suntory Beverage & Food Ltd 549300FONLMVK7YYYH41 SUNTORY BEVERAGE & FOOD LTD 000000000 121600.000000 NS 3967171.920000 1.1947143778 Long EC CORP JP N 2 N N N Cie Financiere Richemont SA 549300YIPGJ6UX2QPS51 CIE FINANCIERE RICHEMONT SA 000000000 37685.000000 NS 5597525.900000 1.6856957066 Long EC CORP CH N 2 N N N National Grid PLC 8R95QZMKZLJX5Q2XR704 NATIONAL GRID PLC 000000000 241719.000000 NS 3219480.660000 0.9695470504 Long EC CORP GB N 2 N N N Unilever PLC 549300MKFYEKVRWML317 UNILEVER PLC 000000000 105866.000000 NS 5160716.270000 1.5541504255 Long EC CORP GB N 2 N N N EXOR NV 5493002ENHZ6NYET7405 EXOR NV 000000000 49857.000000 NS 4823790.620000 1.4526852189 Long EC CORP NL N 2 N N N Investor AB 549300VEBQPHRZBKUX38 INVESTOR AB 000000000 200206.000000 NS 4713805.270000 1.4195631154 Long EC CORP SE N 2 N N N Mondi PLC 213800LOZA69QFDC9N34 MONDI PLC 000000000 202013.182000 NS 3619999.860000 1.0901634634 Long EC CORP GB N 2 N N N GSK PLC 5493000HZTVUYLO1D793 GSK PLC 000000000 227425.000000 NS 4497952.040000 1.3545588850 Long EC CORP GB N 2 N N N Euronext NV 724500QJ4QSZ3H9QU415 EURONEXT NV 000000000 54157.000000 NS 4763495.930000 1.4345274646 Long EC CORP NL N 2 N N N Eurofins Scientific SE 529900JEHFM47DYY3S57 EUROFINS SCIENTIFIC SE 000000000 72620.000000 NS 4372942.190000 1.3169121513 Long EC CORP LU N 2 N N N Shell PLC 21380068P1DRHMJ8KU70 SHELL PLC 000000000 176266.000000 NS 5464656.320000 1.6456820140 Long EC CORP GB N 2 N N N DSM-Firmenich AG 506700G44V67MPM4BI12 DSM-FIRMENICH AG 000000000 28537.000000 NS 3017231.060000 0.9086395551 Long EC CORP CH N 2 N N N Brookfield Corp C6J3FGIWG6MBDGTE8F80 BROOKFIELD CORP 000000000 76959.000000 NS 3054432.850000 0.9198428794 Long EC CORP CA N 2 N N N Hiscox Ltd 5493007JXOLJ0QCY2D70 HISCOX LTD 000000000 388588.000000 NS 5100078.280000 1.5358892863 Long EC CORP BM N 2 N N N CK Hutchison Holdings Ltd 254900Z8HM1VEPOQ2G79 CK HUTCHISON HOLDINGS LTD 000000000 923972.000000 NS 4772150.100000 1.4371336691 Long EC CORP KY N 2 N N N 2024-03-06 T. ROWE PRICE INTERNATIONAL FUNDS, INC. /s/ Alan Dupski Alan Dupski Treasurer & Vice President XXXX NPORT-EX 2 70FNTRP013124.htm T. ROWE PRICE INTERNATIONAL FUNDS, INC.
T.
ROWE
PRICE
International
Disciplined
Equity
Fund
January
31,
2024
(Unaudited)
1
Portfolio
of
Investments
Shares
$
Value
(
Cost
and
value
in
$000s)
AUSTRALIA
1.4%
Common
Stocks
1.4%
BHP
Group
(GBP) 
154,095‌
4,720‌
Total
Australia
(Cost
$3,153
)
4,720‌
BELGIUM
1.9%
Common
Stocks
1.9%
Groupe
Bruxelles
Lambert 
84,217‌
6,385‌
Total
Belgium
(Cost
$6,558
)
6,385‌
CANADA
1.9%
Common
Stocks
1.9%
Brookfield 
78,559‌
3,118‌
Power
Corp.
of
Canada 
112,737‌
3,286‌
Total
Canada
(Cost
$5,187
)
6,404‌
DENMARK
1.0%
Common
Stocks
1.0%
Novozymes,
Class
B (1)
62,180‌
3,186‌
Total
Denmark
(Cost
$3,104
)
3,186‌
FINLAND
1.2%
Common
Stocks
1.2%
Fortum 
297,920‌
4,073‌
Total
Finland
(Cost
$3,806
)
4,073‌
FRANCE
8.7%
Common
Stocks
8.7%
EssilorLuxottica 
18,559‌
3,637‌
Eurofins
Scientific 
72,620‌
4,373‌
Euronext 
48,925‌
4,303‌
Sanofi 
51,831‌
5,191‌
Schneider
Electric 
15,935‌
3,130‌
TotalEnergies 
60,380‌
3,917‌
Wendel 
46,827‌
4,246‌
Total
France
(Cost
$22,727
)
28,797‌
T.
ROWE
PRICE
International
Disciplined
Equity
Fund
2
Shares
$
Value
(Cost
and
value
in
$000s)
GERMANY
8.1%
Common
Stocks
5.4%
BASF 
96,755‌
4,625‌
Bayer 
100,754‌
3,135‌
Continental 
57,226‌
4,675‌
Siemens 
29,963‌
5,364‌
17,799‌
Preferred
Stocks
2.7%
Henkel 
56,381‌
4,322‌
Volkswagen 
36,079‌
4,641‌
8,963‌
Total
Germany
(Cost
$24,796
)
26,762‌
HONG
KONG
3.0%
Common
Stocks
3.0%
CK
Hutchison
Holdings 
923,972‌
4,772‌
Jardine
Matheson
Holdings
(USD) 
131,600‌
5,284‌
Total
Hong
Kong
(Cost
$11,547
)
10,056‌
JAPAN
18.6%
Common
Stocks
18.6%
Hamamatsu
Photonics 
135,300‌
5,345‌
Hoshizaki 
118,400‌
4,308‌
Hoya 
25,500‌
3,239‌
Kao 
93,800‌
3,711‌
Kirin
Holdings 
303,200‌
4,358‌
Mitsubishi
Electric 
289,000‌
4,289‌
Nippon
Sanso
Holdings 
164,900‌
4,179‌
Nippon
Telegraph
&
Telephone 
2,938,000‌
3,689‌
Olympus 
281,800‌
4,172‌
Otsuka
Holdings 
94,600‌
3,719‌
Shimadzu 
178,900‌
4,947‌
Shimano 
32,400‌
4,652‌
Sony
Group 
41,500‌
4,070‌
Suntory
Beverage
&
Food 
121,600‌
3,967‌
Tokyo
Electron 
16,400‌
3,043‌
Total
Japan
(Cost
$55,729
)
61,688‌
T.
ROWE
PRICE
International
Disciplined
Equity
Fund
3
Shares
$
Value
(Cost
and
value
in
$000s)
NETHERLANDS
8.0%
Common
Stocks
8.0%
ASML
Holding 
7,199‌
6,246‌
DSM-Firmenich 
26,695‌
2,822‌
EXOR 
49,857‌
4,824‌
HAL
Trust 
35,697‌
4,450‌
Heineken 
44,608‌
4,487‌
Koninklijke
Philips (2)
171,031‌
3,618‌
Total
Netherlands
(Cost
$18,866
)
26,447‌
NORWAY
1.2%
Common
Stocks
1.2%
Storebrand 
450,035‌
4,046‌
Total
Norway
(Cost
$3,642
)
4,046‌
PHILIPPINES
1.3%
Common
Stocks
1.3%
Ayala 
373,570‌
4,501‌
Total
Philippines
(Cost
$5,001
)
4,501‌
SPAIN
2.5%
Common
Stocks
2.5%
Amadeus
IT
Group 
66,375‌
4,652‌
Iberdrola 
294,872‌
3,550‌
Total
Spain
(Cost
$6,691
)
8,202‌
SWEDEN
4.4%
Common
Stocks
4.4%
Industrivarden,
Class
C (1)
154,520‌
4,856‌
Investor,
Class
204,882‌
4,824‌
L
E
Lundbergforetagen,
Class
B (1)
93,014‌
4,850‌
Total
Sweden
(Cost
$10,173
)
14,530‌
SWITZERLAND
8.3%
Common
Stocks
8.3%
Barry
Callebaut 
3,106‌
4,537‌
T.
ROWE
PRICE
International
Disciplined
Equity
Fund
4
Shares
$
Value
(Cost
and
value
in
$000s)
Cie
Financiere
Richemont 
37,685‌
5,597‌
Nestle 
60,553‌
6,900‌
Novartis 
41,918‌
4,335‌
Roche
Holding 
21,380‌
6,087‌
Total
Switzerland
(Cost
$25,303
)
27,456‌
UNITED
KINGDOM
20.6%
Common
Stocks
20.6%
Anglo
American 
196,322‌
4,680‌
BP 
966,027‌
5,642‌
Diageo 
127,514‌
4,606‌
Experian 
75,521‌
3,143‌
GSK 
222,873‌
4,408‌
Hiscox 
388,588‌
5,100‌
HSBC
Holdings 
567,206‌
4,429‌
Lloyds
Banking
Group 
7,954,463‌
4,264‌
Mondi 
232,096‌
4,159‌
National
Grid 
241,719‌
3,219‌
Prudential 
553,533‌
5,686‌
Shell 
176,266‌
5,465‌
Smith
&
Nephew 
297,870‌
4,166‌
Smiths
Group 
234,499‌
4,806‌
Unilever
(EUR) 
97,902‌
4,772‌
Total
United
Kingdom
(Cost
$66,809
)
68,545‌
UNITED
STATES
2.7%
Exchange-Traded
Funds
2.7%
iShares
MSCI
EAFE
ETF (1)
119,700‌
8,979‌
Total
United
States
(Cost
$8,344
)
8,979‌
SHORT-TERM
INVESTMENTS
4.2%
Money
Market
Funds
4.2%
T.
Rowe
Price
Government
Reserve
Fund,
5.40% (3)(4)
14,101,251‌
14,101‌
Total
Short-Term
Investments
(Cost
$14,101)
14,101‌
T.
ROWE
PRICE
International
Disciplined
Equity
Fund
5
Shares
$
Value
(Cost
and
value
in
$000s)
SECURITIES
LENDING
COLLATERAL
4.7%
INVESTMENTS
IN
A
POOLED
ACCOUNT
THROUGH
SECURITIES
LENDING
PROGRAM
WITH
JPMORGAN
CHASE
BANK
4.7%
Money
Market
Funds
4.7%
T.
Rowe
Price
Government
Reserve
Fund,
5.40% (3)(4)
15,481,909‌
15,482‌
Total
Investments
in
a
Pooled
Account
through
Securities
Lending
Program
with
JPMorgan
Chase
Bank
15,482‌
Total
Securities
Lending
Collateral
(Cost
$15,482)
15,482‌
Total
Investments
in
Securities
103.7%
(Cost
$311,019)
$
344,360‌
Other
Assets
Less
Liabilities
(3.7)%
(12,323)
Net
Assets
100.0%
$
332,037‌
Country
classifications
are
generally
based
on
MSCI
categories
or
another
unaffiliated
third
party
data
provider;
Shares
are
denominated
in
the
currency
of
the
country
presented
unless
otherwise
noted.
(1)
All
or
a
portion
of
this
security
is
on
loan
at
January
31,
2024.
(2)
Non-income
producing
(3)
Seven-day
yield
(4)
Affiliated
Companies
ETF
Exchange-Traded
Fund
EUR
Euro
GBP
British
Pound
USD
U.S.
Dollar
T.
ROWE
PRICE
International
Disciplined
Equity
Fund
6
The
accompanying
notes
are
an
integral
part
of
this
Portfolio
of
Investments.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
three
months
ended
January
31,
2024.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
T.
Rowe
Price
Government
Reserve
Fund,
5.40%
$
—‌
$
—‌
$
175‌++
Totals
$
—‌#
$
—‌
$
175‌+
Supplementary
Investment
Schedule
Affiliate
Value
10/31/23
Purchase
Cost
Sales
Cost
Value
01/31/24
T.
Rowe
Price
Government
Reserve
Fund,
5.40%
$
7,200‌
 ¤
 ¤
$
29,583‌
Total
$
29,583‌^
#
Capital
gain
distributions
from
underlying
Price
funds
represented
$0
of
the
net
realized
gain
(loss).
++
Excludes
earnings
on
securities
lending
collateral,
which
are
subject
to
rebates
and
fees.
+
Investment
income
comprised
$175
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$29,583.
T.
ROWE
PRICE
International
Disciplined
Equity
Fund
Unaudited
Notes
to
Portfolio
of
Investments
7
T.
Rowe
Price
International
Disciplined
Equity
Fund (the
fund) is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act)
as
an
open-end
management
investment
company
and
follows
accounting
and
reporting
guidance
of
the
Financial
Accounting
Standards
Board
Accounting
Standards
Codification
Topic
946.
The
accompanying
Portfolio
of
Investments
was
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP).
For
additional
information
on
the
fund’s
significant
accounting
policies
and
investment
related
disclosures,
please
refer
to
the
fund’s most
recent
semiannual
or
annual
shareholder
report
and
its
prospectus. 
VALUATION 
Fair
Value
  The
fund’s
financial
instruments
are
valued
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business,
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The fund’s
Board
of
Directors
(the
Board)
has
designated
T.
Rowe
Price
Associates,
Inc.
as
the
fund’s
valuation
designee
(Valuation
Designee).
Subject
to
oversight
by
the
Board,
the
Valuation
Designee
performs
the
following
functions
in
performing
fair
value
determinations:
assesses
and
manages
valuation
risks;
establishes
and
applies
fair
value
methodologies;
tests
fair
value
methodologies;
and
evaluates
pricing
vendors
and
pricing
agents.
The
duties
and
responsibilities
of
the
Valuation
Designee
are
performed
by
its
Valuation
Committee. The
Valuation
Designee provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
Level
2
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
T.
ROWE
PRICE
International
Disciplined
Equity
Fund
8
Level
3
unobservable
inputs
(including
the Valuation
Designee’s assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the Valuation
Designee
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of
its portfolio
securities.
Each
business
day,
the
Valuation
Designee uses
information
from
outside
pricing
services
to
evaluate
the
quoted
prices
of
portfolio
securities
and,
if
appropriate,
decide whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value
by
reviewing
a
variety
of
factors,
including
developments
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The Valuation
Designee
uses
outside
pricing
services
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The Valuation
Designee
cannot
predict
how
often
it
will
use
quoted
prices
and
how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
T.
ROWE
PRICE
International
Disciplined
Equity
Fund
9
Investments
denominated
in
foreign
currencies
are
translated
into
U.S.
dollar
values
each
day
at
the
prevailing
exchange
rate,
using
the
mean
of
the
bid
and
asked
prices
of
such
currencies
against
U.S.
dollars
as
provided
by
an
outside
pricing
service.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Investments
for
which
market
quotations are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Designee.
The
Valuation
Designee
has
adopted
methodologies
for
determining
the
fair
value
of
investments
for
which
market
quotations
are
not
readily
available
or
deemed
unreliable,
including
the
use
of
other
pricing
sources.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Designee typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Designee may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions. Fair
value
prices
determined
by
the
Valuation
Designee could
differ
from
those
of
other
market
participants,
and
it
is
possible
that
the
fair
value
determined
for
a
security
may
be
materially
different
from
the
value
that
could
be
realized
upon
the
sale
of
that
security.
T.
ROWE
PRICE
International
Disciplined
Equity
Fund
10
Valuation
Inputs
  The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
January
31,
2024
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
OTHER
MATTERS 
Unpredictable
events
such
as
environmental
or
natural
disasters,
war
and
conflict,
terrorism,
geopolitical
events,
and
public
health
epidemics and
similar
public
health
threats
may
significantly
affect
the
economy
and
the
markets
and
issuers
in
which
the fund
invests.
Certain
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others,
and
exacerbate
other
pre-existing
political,
social,
and
economic
risks.
The
global
outbreak
of
COVID-19
and
the
related
governmental
and
public
responses
have
led
and
may
continue
to
lead
to
increased
market
volatility
and
the
potential
for
illiquidity
in
certain
classes
of
securities
and
sectors
of
the
market
either
in
specific
countries
or
worldwide.
In
February
2022,
Russian
forces
entered
Ukraine
and
commenced
an
armed
conflict,
leading
to
economic
sanctions imposed
on
Russia
that
target certain
of
its
citizens
and
issuers
and
sectors
of
the
Russian
economy,
creating
impacts
on
Russian-related
stocks
and
debt
and
greater
volatility
in
global
markets.
In
March
2023,
the
banking
industry
experienced
heightened
volatility,
which
sparked
concerns
of
potential
broader
adverse
market
conditions.
The
extent
of
impact
of
these
events
on
the
US
and
global
markets
is
highly
uncertain.
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Common
Stocks
$
—‌
$
296,835‌
$
—‌
$
296,835‌
Exchange-Traded
Funds
8,979‌
—‌
—‌
8,979‌
Preferred
Stocks
—‌
8,963‌
—‌
8,963‌
Short-Term
Investments
14,101‌
—‌
—‌
14,101‌
Securities
Lending
Collateral
15,482‌
—‌
—‌
15,482‌
Total
$
38,562‌
$
305,798‌
$
—‌
$
344,360‌
T.
ROWE
PRICE
International
Disciplined
Equity
Fund
11
These
are
recent
examples
of
global
events
which
may
have
a
negative
impact
on
the
values
of
certain
portfolio
holdings
or
the
fund's
overall
performance.
Management
is
actively
monitoring
the
risks
and
financial
impacts
arising
from
these
events.
F106-054Q1
01/24